Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of 1.12 trillion as of October 31, 2025. Its market cap has increased by 45.68% in one year.

Market Cap

1.12T

Enterprise Value

1.12T

Revenue

58.88B

Ranking

n/a

PE Ratio

1,399.48

Stock Price

8,380.00

Market Cap Chart

Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 1.32B to 1.12T, an increase of 84,439.66%. That is a compound annual growth rate of 36.94%.

Market Cap History

Date	Market Cap	% Change
Oct 31, 2025	1.12T	76.83%
Dec 31, 2024	632.43B	55.74%
Dec 29, 2023	406.09B	-28.80%
Dec 30, 2022	570.31B	37.16%
Dec 31, 2021	415.79B	38.38%
Dec 31, 2020	300.47B	24.07%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	1.05T
Grupo Financiero Banorte	481.96B
Arca Continental	303.51B
Industrias Peñoles	300.13B
GMéxico Transportes	145.30B
FIBRA Prologis	118.93B
Fibra UNO	104.26B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	103.91B

Market Cap Rankings